These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 16286122

  • 1. Prognostic significance of perineural invasion on biochemical progression-free survival after prostate brachytherapy.
    Merrick GS, Butler WM, Wallner KE, Galbreath RW, Allen ZA, Adamovich E.
    Urology; 2005 Nov; 66(5):1048-53. PubMed ID: 16286122
    [Abstract] [Full Text] [Related]

  • 2. Permanent interstitial brachytherapy in younger patients with clinically organ-confined prostate cancer.
    Merrick GS, Butler WM, Wallner KE, Galbreath RW, Adamovich E.
    Urology; 2004 Oct; 64(4):754-9. PubMed ID: 15491715
    [Abstract] [Full Text] [Related]

  • 3. Perineural invasion is not predictive of biochemical outcome following prostate brachytherapy.
    Merrick GS, Butler WM, Galbreath RW, Lief JH, Adamovich E.
    Cancer J; 2001 Oct; 7(5):404-12. PubMed ID: 11693899
    [Abstract] [Full Text] [Related]

  • 4. Influence of body mass index on biochemical outcome after permanent prostate brachytherapy.
    Merrick GS, Butler WM, Wallner KE, Galbreath RW, Allen Z, Lief JH, Adamovich E.
    Urology; 2005 Jan; 65(1):95-100. PubMed ID: 15667872
    [Abstract] [Full Text] [Related]

  • 5. Impact of supplemental external beam radiotherapy and/or androgen deprivation therapy on biochemical outcome after permanent prostate brachytherapy.
    Merrick GS, Butler WM, Wallner KE, Galbreath RW, Lief JH, Allen Z, Adamovich E.
    Int J Radiat Oncol Biol Phys; 2005 Jan 01; 61(1):32-43. PubMed ID: 15629591
    [Abstract] [Full Text] [Related]

  • 6. Association of percent positive prostate biopsies and perineural invasion with biochemical outcome after external beam radiotherapy for localized prostate cancer.
    Wong WW, Schild SE, Vora SA, Halyard MY.
    Int J Radiat Oncol Biol Phys; 2004 Sep 01; 60(1):24-9. PubMed ID: 15337536
    [Abstract] [Full Text] [Related]

  • 7. Monotherapeutic brachytherapy for clinically organ-confined prostate cancer.
    Merrick GS, Butler WM, Wallner KE, Galbreath RW, Adamovich E.
    W V Med J; 2005 Sep 01; 101(4):168-71. PubMed ID: 16296198
    [Abstract] [Full Text] [Related]

  • 8. Effect of cigarette smoking on biochemical outcome after permanent prostate brachytherapy.
    Merrick GS, Butler WM, Wallner KE, Galbreath RW, Lief JH, Adamovich E.
    Int J Radiat Oncol Biol Phys; 2004 Mar 15; 58(4):1056-62. PubMed ID: 15001245
    [Abstract] [Full Text] [Related]

  • 9. Perineural invasion affects biochemical recurrence-free survival in patients with prostate cancer treated with definitive external beam radiotherapy.
    Yu HH, Song DY, Tsai YY, Thompson T, Frassica DA, DeWeese TL.
    Urology; 2007 Jul 15; 70(1):111-6. PubMed ID: 17656219
    [Abstract] [Full Text] [Related]

  • 10. Statins, especially atorvastatin, may favorably influence clinical presentation and biochemical progression-free survival after brachytherapy for clinically localized prostate cancer.
    Moyad MA, Merrick GS, Butler WM, Wallner KE, Galbreath RW, Kurko B, Adamovich E.
    Urology; 2005 Dec 15; 66(6):1150-4. PubMed ID: 16360430
    [Abstract] [Full Text] [Related]

  • 11. Prognostic significance of the diameter of perineural invasion in radical prostatectomy specimens.
    Maru N, Ohori M, Kattan MW, Scardino PT, Wheeler TM.
    Hum Pathol; 2001 Aug 15; 32(8):828-33. PubMed ID: 11521227
    [Abstract] [Full Text] [Related]

  • 12. Perineural invasion on prostate needle biopsy does not predict biochemical failure following brachytherapy for prostate cancer.
    Weight CJ, Ciezki JP, Reddy CA, Zhou M, Klein EA.
    Int J Radiat Oncol Biol Phys; 2006 Jun 01; 65(2):347-50. PubMed ID: 16545922
    [Abstract] [Full Text] [Related]

  • 13. Intermediate-risk localized prostate cancer in the PSA era: radiotherapeutic alternatives.
    Gondi V, Deutsch I, Mansukhani M, O'Toole KM, Shah JN, Schiff PB, Katz AE, Benson MC, Goluboff ET, Ennis RD.
    Urology; 2007 Mar 01; 69(3):541-6. PubMed ID: 17382161
    [Abstract] [Full Text] [Related]

  • 14. Perineural invasion and seminal vesicle involvement predict pelvic lymph node metastasis in men with localized carcinoma of the prostate.
    Stone NN, Stock RG, Parikh D, Yeghiayan P, Unger P.
    J Urol; 1998 Nov 01; 160(5):1722-6. PubMed ID: 9783940
    [Abstract] [Full Text] [Related]

  • 15. Brachytherapy in men aged < or = 54 years with clinically localized prostate cancer.
    Merrick GS, Wallner KE, Butler WM, Galbreath RW, Allen ZA, Adamovich E, True L.
    BJU Int; 2006 Aug 01; 98(2):324-8. PubMed ID: 16879672
    [Abstract] [Full Text] [Related]

  • 16. High dose rate (HDR) brachytherapy with conformal radiation therapy for localized prostate cancer.
    Deger S, Boehmer D, Roigas J, Schink T, Wernecke KD, Wiegel T, Hinkelbein W, Budach V, Loening SA.
    Eur Urol; 2005 Apr 01; 47(4):441-8. PubMed ID: 15774239
    [Abstract] [Full Text] [Related]

  • 17. Long-term outcomes after treatment with brachytherapy and supplemental conformal radiation for prostate cancer patients having intermediate and high-risk features.
    Dattoli M, Wallner K, True L, Cash J, Sorace R.
    Cancer; 2007 Aug 01; 110(3):551-5. PubMed ID: 17577217
    [Abstract] [Full Text] [Related]

  • 18. Androgen-deprivation therapy does not impact cause-specific or overall survival after permanent prostate brachytherapy.
    Merrick GS, Butler WM, Wallner KE, Galbreath RW, Allen ZA, Adamovich E.
    Int J Radiat Oncol Biol Phys; 2006 Jul 01; 65(3):669-77. PubMed ID: 16682149
    [Abstract] [Full Text] [Related]

  • 19. Prostate-specific antigen (PSA) velocity and benign prostate hypertrophy predict for PSA spikes following prostate brachytherapy.
    Merrick GS, Butler WM, Wallner KE, Lief JH, Hinerman-Mulroy A, Galbreath RW.
    Brachytherapy; 2003 Jul 01; 2(3):181-8. PubMed ID: 15062141
    [Abstract] [Full Text] [Related]

  • 20. PSA kinetics after prostate brachytherapy: PSA bounce phenomenon and its implications for PSA doubling time.
    Ciezki JP, Reddy CA, Garcia J, Angermeier K, Ulchaker J, Mahadevan A, Chehade N, Altman A, Klein EA.
    Int J Radiat Oncol Biol Phys; 2006 Feb 01; 64(2):512-7. PubMed ID: 16213667
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.